StockComparison Logo
vs

XGN vs IMDX

Comparison between Exagen Inc (XGN, Company) and Insight Molecular Diagnostics Inc (IMDX, Company).

Both XGN and IMDX are from the Healthcare sector.

5-Year PerformanceXGN has outperformed IMDX, delivering a return of -8.7% compared to -44.8%

XGN vs IMDX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
XGN
$161M
Winner
IMDX
$161M
Max Drawdown
Winner
XGN
95.22%
IMDX
99.03%
Sharpe Ratio
XGN
-0.03
Winner
IMDX
1.05
5Y Beta
XGN
1.70
Winner
IMDX
0.83
Industry
XGN
Diagnostics & Research
IMDX
Diagnostics & Research
P/E Ratio
Winner
XGN
-8.15
IMDX
-3.03
5Y EPS CAGR
Winner
XGN
-9.18%
IMDX
-25.97%
Debt to Equity
XGN
186.96%
Winner
IMDX
0.00%
Free Cash Flow Yield
Winner
XGN
-4.72%
IMDX
-17.01%

XGN vs IMDX - Historical Returns

Returns include dividend reinvestment.

1M
Winner
XGN
+51.14%
IMDX
-11.35%
3M
Winner
XGN
+115.21%
IMDX
+9.17%
6M
Winner
XGN
+97.92%
IMDX
-25.26%
1Y
XGN
-25.03%
Winner
IMDX
+91.57%
5Y(CAGR)
Winner
XGN
-8.73%
IMDX
-44.76%
10Y(CAGR)
XGN
N/A
IMDX
-24.10%
Max(CAGR)
Winner
XGN
-13.88%
IMDX
-28.72%

XGN vs IMDX - Annual Returns (2016 - 2026)

Returns include dividend reinvestment.

YearXGNIMDX
2026+10.10%-30.17%
2025+96.76%+221.89%
2024+108.12%-27.88%
2023-19.11%-63.77%
2022-78.30%-85.74%
2021-16.33%-9.21%
2020-49.13%+7.17%
2019+36.71%+53.06%
2018N/A-70.00%
2017N/A-31.11%
2016N/A-21.67%

XGN vs IMDX Drawdown Comparison

The maximum drawdown for XGN was -95.22%, occurring on May 1, 2024. This drawdown has not yet recovered.

The maximum drawdown for IMDX was -99.03%, occurring on Jan 22, 2025. This drawdown has not yet recovered.

The current XGN drawdown is -76.65%. The current IMDX drawdown is -97.53%.

RankXGNIMDX
#1-95.22%
Dec 26, 2019 - May 1, 2024
-99.03%
Jan 5, 2016 - Jan 22, 2025
#2-32.13%
Sep 19, 2019 - Nov 5, 2019
N/A
#3-16.54%
Nov 6, 2019 - Dec 18, 2019
N/A

Correlation

Correlation between XGN and IMDX is 0.77 which considered as a strong positive correlation - the stocks tend to move together.

0.77
-101

Select Stocks to Compare